369 related articles for article (PubMed ID: 26115674)
1. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage.
Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ
Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.
Wang J; Pang T; Hafko R; Benicky J; Sanchez-Lemus E; Saavedra JM
Neuropharmacology; 2014 Apr; 79():249-61. PubMed ID: 24316465
[TBL] [Abstract][Full Text] [Related]
3. Let's be certain about sartans (and other potential new therapies for CNS injury).
Moon L
Brain; 2015 Nov; 138(Pt 11):3136-9. PubMed ID: 26503939
[No Abstract] [Full Text] [Related]
4. Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice.
Villapol S; Yaszemski AK; Logan TT; Sánchez-Lemus E; Saavedra JM; Symes AJ
Neuropsychopharmacology; 2012 Dec; 37(13):2817-29. PubMed ID: 22892395
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
Kasahara Y; Taguchi A; Uno H; Nakano A; Nakagomi T; Hirose H; Stern DM; Matsuyama T
Brain Res; 2010 Jun; 1340():70-80. PubMed ID: 20388500
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
7. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.
Elkahloun AG; Rodriguez Y; Alaiyed S; Wenzel E; Saavedra JM
Mol Neurobiol; 2019 May; 56(5):3193-3210. PubMed ID: 30105672
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
[TBL] [Abstract][Full Text] [Related]
11. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway.
Pang T; Sun LX; Wang T; Jiang ZZ; Liao H; Zhang LY
Acta Pharmacol Sin; 2014 Jun; 35(6):727-37. PubMed ID: 24793312
[TBL] [Abstract][Full Text] [Related]
13. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
[TBL] [Abstract][Full Text] [Related]
14. Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Torika N; Asraf K; Cohen H; Fleisher-Berkovich S
Brain Behav Immun; 2017 Aug; 64():80-90. PubMed ID: 28385651
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
[TBL] [Abstract][Full Text] [Related]
16. Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.
Zhang J; Liu X; Wang SQ; Liu GY; Xu WR; Cheng XC; Wang RL
J Biomol Struct Dyn; 2017 Sep; 35(12):2665-2680. PubMed ID: 27602589
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism.
Saravanan PB; Shanmuganathan MV; Ramanathan M
Life Sci; 2015 Jun; 130():88-96. PubMed ID: 25816983
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.
Walcher D; Hess K; Heinz P; Petscher K; Vasic D; Kintscher U; Clemenz M; Hartge M; Raps K; Hombach V; Marx N
Hypertension; 2008 Feb; 51(2):259-66. PubMed ID: 18158351
[TBL] [Abstract][Full Text] [Related]
19. Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism.
Haraguchi T; Takasaki K; Naito T; Hayakawa K; Katsurabayashi S; Mishima K; Iwasaki K; Fujiwara M
Neurosci Lett; 2009 Oct; 464(3):151-5. PubMed ID: 19699780
[TBL] [Abstract][Full Text] [Related]
20. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
